Pfizer Sues To Block Lupin's Generic Bladder-Control Drug
By Linda Chiem ( March 27, 2013, 5:26 PM EDT) -- Pfizer Inc. has launched suit in New Jersey federal court accusing generic-drug maker Lupin Ltd. of infringing Pfizer's patents for the overactive-bladder drug Detrol LA by seeking federal approval to make a generic version before the patents expire....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.